• Publications
  • Influence
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.
The therapeutic effectiveness of 131I treatment in patients with elevated Tg and negative diagnostic whole body scans is indicated by the conversion to negative RxWBS, the statistically significant decrease in the mean Tg level, and the reduction of serum Tg to 5 ng/mL or less in 50% of patients. Expand
Proteins associated with the thyroid hormones.
Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
It is confirmed that near-total thyroidectomy is indicated in high-risk patients and radioactive iodine therapy is beneficial for stage II, III, and IV patients, and it is shown for the first time that superior outcomes are associated with aggressive thyroid hormone suppression therapy in high risk patients, but are achieved with modest suppression in stage II patients. Expand
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
The relation of TSH suppression to baseline disease characteristics and to the likelihood of disease progression in a cohort of thyroid cancer patients who have been followed in a multicenter thyroid cancer registry is examined. Expand
A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening.
Exposure to radioactive iodine was strongly associated with increased risk of thyroid cancer among those exposed as children and adolescents following the Chornobyl accident. Expand
Chernobyl-related thyroid cancer in children of Belarus: a case-control study.
Case-control comparisons indicate a strong relationship between thyroid cancer and estimated radiation dose from the Chernobyl accident and differences persisted within pathway to diagnosis, gender, age and year of diagnosis, and level of iodine in the soil. Expand
Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
  • Terry Taylor, B. Specker, +16 authors H. Maxon
  • Medicine
  • Annals of Internal Medicine
  • 15 October 1998
Outcomes in patients with high-risk, differentiated thyroid cancer are described, a group of patients expected to have substantial morbidity and mortality in this time period. Expand
Thyroid hormone transport proteins.
TBG, TTR, and albumin are quantitatively the most important thyroid hormone binding proteins in humans, and thyroid hormone-binding protein abnormalities must be suspected when abnormally elevated or diminished total thyroid hormone concentrations are encountered in clinically euthyroid subjects. Expand
A Cohort Study of Thyroid Cancer and Other Thyroid Diseases after the Chornobyl Accident: Objectives, Design and Methods
An ongoing cohort study being conducted in Belarus and Ukraine that includes 25,161 subjects under the age of 18 years in 1986 who are being screened for thyroid diseases every 2 years will enable fitting appropriate dose–response models, which are important in both radiation epidemiology and public health for prediction of risks from exposure to radioactive iodine from medical sources and any future nuclear accidents. Expand